BioCentury | Feb 15, 2016
Financial News

Karo Bio proposes rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2016-02-12 Type: Rights offering To be raised: Up to SEK249.6 million ($29.6 million) Shares: 12.5 million Price: SEK20 Shares outstanding prior: 49.9 million Investor: Existing...
BioCentury | Jun 8, 2015
Company News

Tanomed, Karo Bio deal

...to provide further details, and Tanomed could not be reached. Tanomed AB , Umea, Sweden Karo Bio AB...
BioCentury | May 4, 2015
Financial News

Karo Bio proposes rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2015-04-29 Type: Rights offering To be raised: Up to SEK229.9 million ($26.6 million) Shares: 229.9 million Price: SEK1 Shares outstanding prior: 676.3 million Investor: Existing...
BioCentury | May 5, 2014
Financial News

Karo Bio completes private placement

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date completed: 4/30/14 Type: Private placement Raised: SEK7.1 million ($1.1 million) Shares: 15 million Price: SEK0.47 Shares after offering: 676.3 million Investor: Individual investor Note: The shares...
BioCentury | May 5, 2014
Financial News

Karo Bio completes rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date completed: 4/30/14 Type: Rights offering Raised: SEK77.7 million ($11.9 million) Shares: 165.3 million Price: SEK0.47 Shares after offering: 676.3 million Note: Shareholders were eligible to purchase...
BioCentury | Feb 17, 2014
Financial News

Karo Bio proposes rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2/13/14 Type: Rights offering To be raised: Up to SEK77.7 million ($12 million) Shares: 165.3 million Price: SEK0.47 Note: Shareholders will be eligible to purchase...
BioCentury | Feb 17, 2014
Financial News

Karo Bio proposes private placement

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2/13/14 Type: Private placement To be raised: Up to SEK7.1 million ($1.1 million) Shares: 15 million Price: SEK0.47 Shares outstanding prior: 495.9 million WIR Staff...
BioCentury | Sep 30, 2013
Company News

4D Science, Karo Bio deal

...based on 4D Science discoveries, which include fibrotic disease models used to evaluate drug candidates. Karo Bio...
...collaboration. The companies could not be reached for details. 4D Science GmbH , undisclosed location Karo Bio AB...
BioCentury | Sep 16, 2013
Company News

Karo Bio, Pfizer deal

...royalties. Karo Bio declined to provide details (see BioCentury, Jan. 2, 2012 & July, 15, 2013). Karo Bio AB...
BioCentury | Jul 15, 2013
Company News

Karo Bio, Pfizer deal

...to Karo Bio's existing RORgamma modulators as well as to any products discovered under the deal. Karo Bio...
...to $217 million in upfront and milestone payments, plus royalties (see BioCentury, Jan. 2, 2012). Karo Bio AB...
Items per page:
1 - 10 of 242
BioCentury | Feb 15, 2016
Financial News

Karo Bio proposes rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2016-02-12 Type: Rights offering To be raised: Up to SEK249.6 million ($29.6 million) Shares: 12.5 million Price: SEK20 Shares outstanding prior: 49.9 million Investor: Existing...
BioCentury | Jun 8, 2015
Company News

Tanomed, Karo Bio deal

...to provide further details, and Tanomed could not be reached. Tanomed AB , Umea, Sweden Karo Bio AB...
BioCentury | May 4, 2015
Financial News

Karo Bio proposes rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2015-04-29 Type: Rights offering To be raised: Up to SEK229.9 million ($26.6 million) Shares: 229.9 million Price: SEK1 Shares outstanding prior: 676.3 million Investor: Existing...
BioCentury | May 5, 2014
Financial News

Karo Bio completes private placement

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date completed: 4/30/14 Type: Private placement Raised: SEK7.1 million ($1.1 million) Shares: 15 million Price: SEK0.47 Shares after offering: 676.3 million Investor: Individual investor Note: The shares...
BioCentury | May 5, 2014
Financial News

Karo Bio completes rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date completed: 4/30/14 Type: Rights offering Raised: SEK77.7 million ($11.9 million) Shares: 165.3 million Price: SEK0.47 Shares after offering: 676.3 million Note: Shareholders were eligible to purchase...
BioCentury | Feb 17, 2014
Financial News

Karo Bio proposes rights offering

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2/13/14 Type: Rights offering To be raised: Up to SEK77.7 million ($12 million) Shares: 165.3 million Price: SEK0.47 Note: Shareholders will be eligible to purchase...
BioCentury | Feb 17, 2014
Financial News

Karo Bio proposes private placement

Karo Bio AB (SSE:KARO), Stockholm, Sweden Business: Endocrine/Metabolic Date announced: 2/13/14 Type: Private placement To be raised: Up to SEK7.1 million ($1.1 million) Shares: 15 million Price: SEK0.47 Shares outstanding prior: 495.9 million WIR Staff...
BioCentury | Sep 30, 2013
Company News

4D Science, Karo Bio deal

...based on 4D Science discoveries, which include fibrotic disease models used to evaluate drug candidates. Karo Bio...
...collaboration. The companies could not be reached for details. 4D Science GmbH , undisclosed location Karo Bio AB...
BioCentury | Sep 16, 2013
Company News

Karo Bio, Pfizer deal

...royalties. Karo Bio declined to provide details (see BioCentury, Jan. 2, 2012 & July, 15, 2013). Karo Bio AB...
BioCentury | Jul 15, 2013
Company News

Karo Bio, Pfizer deal

...to Karo Bio's existing RORgamma modulators as well as to any products discovered under the deal. Karo Bio...
...to $217 million in upfront and milestone payments, plus royalties (see BioCentury, Jan. 2, 2012). Karo Bio AB...
Items per page:
1 - 10 of 242